Functional T cell immunodeficiency characterized by defective TCR/CD3 induced tyrosylphosphorylation

Autor: Claire Hivroz, Le Deist F, Ha, Buc, Griscelli C, Fischer A

Publikováno v: Europe PubMed Central

Defective T cell activation has been recognized in a number of patients with primary immunodeficiencies (ID). A distal defect resulting in abnormal production of IL2, IL3, IL4 and IFN gamma was found to be associated with reduced binding of the NF-AT

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9cb347a49662dc032c9df6937eae104c
https://pubmed.ncbi.nlm.nih.gov/8167686

Regulation of adenylyl cyclase activity in human peripheral blood mononuclear cells: effects of protein kinase inhibitors and of a calcium ionophore.

Autor: Buc HA; Laboratoire de biochimie métabolique et pharmacologique, INSERM U75, and Faculté de Médecine Necker-Enfants Malades, Université Paris V, France., Moncion A, Pérignon JL

Publikováno v: International journal of immunopharmacology [Int J Immunopharmacol] 1998 Sep; Vol. 20 (9), pp. 445-55.

A primary T-cell immunodeficiency associated with defective transmembrane calcium influx.

Autor: Le Deist F; INSERM U132, Hôpital Necker Enfants Malades, Paris, France., Hivroz C, Partiseti M, Thomas C, Buc HA, Oleastro M, Belohradsky B, Choquet D, Fischer A

Publikováno v: Blood [Blood] 1995 Feb 15; Vol. 85 (4), pp. 1053-62.

Functional T cell immunodeficiency characterized by defective TCR/CD3 induced tyrosylphosphorylation.

Autor: Hivroz C; INSERM U 132, Paris, France., Le Deist F, Buc HA, Griscelli C, Fischer A

Publikováno v: Immunodeficiency [Immunodeficiency] 1993; Vol. 4 (1-4), pp. 131-2.

Influence of adenosine deaminase inhibition on the phosphoinositide turnover in the initial stages of human T cell activation.

Autor: Buc HA; Faculté de Médecine, Necker-Enfants Malades, INSERM U75, Paris, France., Moncion A, Hamet M, Houllier AM, Thuilier L, Perignon JL

Publikováno v: European journal of immunology [Eur J Immunol] 1990 Mar; Vol. 20 (3), pp. 611-5.